Generic Biosimilar Medicines Association

Making Medicines Affordable

  • Home
  • About GBMA
    • Contact us
    • GBMA Members
    • GBMA Executive and Board
    • Guiding principles
    • Code of Practice
      • Code Complaint Committee
      • Historical Event Reporting
      • Annual Review
        • 2011
        • 2012
        • 2013
        • 2014
        • 2015
        • 2016
        • 2017
        • 2018
        • 2019
        • 2020
        • 2021
        • 2022
      • Lodging a complaint
    • Media Enquiries
    • Our Objectives
    • Links
  • Advocacy
    • New 5-year Strategic Agreement
    • Extended Strategic Agreement
    • Generic Medicines Working Group (GMWG)
    • Submissions
  • Generics
    • Facts and Fallacies
    • Key Figures on Generic Medicines
    • What is a Generic Medicine?
    • Bioequivalence Explained
  • Biosimilars
    • IGBA Global Biosimilars Week
    • GBMA Position on Biosimilars
      • Impact of Biosimilars
      • Switching
      • Pharmacy Substitution
      • Regulation
      • Awareness and Uptake
      • Naming
    • Key Figures on Biosimilars
  • Topics
    • International Generic and Biosimilar Medicines Association (IGBA)
    • Price Disclosure
    • Intellectual Property
    • International Trade Agreements
  • News
    • News 2023
    • News 2022
    • News 2021
    • News 2020
    • News 2019
    • News 2018
    • News 2017
    • News 2016
    • News 2015
    • News 2014
  • GBMA Education
  • COVID-19 Virus
    • COVID-19 Virus: The Facts
GBMA00280 Global Biosimilars Week Header 2023
GBMA00280 Global Biosimilars Week Header 2023
home_tile_1
home_tile_1
home_tile_2
home_tile_2
home_tile_3
home_tile_3
GBMA00281 GBMA Executive and Board Header 2023
GBMA00281 GBMA Executive and Board Header 2023

Generic Medicines: The Facts

Generic Medicines Facts

Generic medicines are quality medicines at affordable prices. Ask your doctor to prescribe a generic medicine, or ask for a generic medicine next time you take your prescription to the pharmacy. … More…

Key Figures on Biosimilars

Key Figures on Biosimilars

A biosimilar medicine is a highly similar version of an original brand of medicine. Introduction into the market provides competition and can trigger price reductions to the PBS through a process … More…

Our Members

Sandoz Logo
Sandoz Logo Sandoz Blue RGB
PRIMARY_neo_health_logo_RGB[86]
PRIMARY_neo_health_logo_RGB[86]
logo_ACCORD
logo_ACCORD
Organon logo
Organon logo
Gedeon_Richter_HOR_CMYK-01
Gedeon_Richter_HOR_CMYK-01
Juno
Juno
Teva
Teva
Viatris
Viatris
Arrow logo
Arrow logo
apotex
apotex
Fresnius Kabi
Fresnius Kabi
Fresnius Kabi
CommEyes_Logo_Full (3)
CommEyes_Logo_Full (3)
sinapse
sinapse
PearceIP-Masterbrand-CMYK-tag
PearceIP-Masterbrand-CMYK-tag

IGBA’s Annual Global Biosimilars Week Focuses on Oncology Care

November 14, 2023

Tuesday, November 14, 2023 Geneva, Switzerland In the week … More...

Neo Health joins GBMA under new membership tier

September 28, 2023

Thursday, September 28, 2023 Canberra, … More...

GBMA welcomes Teva Pharma to its growing membership base

July 24, 2023

Tuesday July 25, 2023 Canberra, … More…

© 2023 Generic and Biosimilar Medicines Association Pty Ltd | Privacy Policy | Contact Us